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      The carcinogenicity of nickel compounds has been confirmed by numerous epidemiological 
studies in humans and animals.[1] A possible way to better understand the molecular 
mechanisms implicated in toxicity and carcinogenicity of nickel compounds is to study the 
characteristics of the proteins expressed by the genes specifically induced by these carcinogens. 
      Cap43 is an excellent tumor marker recently discovered. Exposure to either soluble or 
insoluble nickel compounds strongly activated several hypoxia-inducible genes.[2] Cap43 is one 
of these genes, and it expressed a 3.0-kb mRNA encoding a Mr 43,000 protein.[3] The primary 
signal for its induction is an elevation of free intracellular calcium ion caused by nickel ion 
exposure in cultured human cells, for this reason is named Cap43: Calcium protein 43,000. The 
peculiarity of protein Cap43 is its new mono-histidinic motif consisting of ten amino acids 
TRSRSHTSEG repeated three times in the C-terminus. 
      We have analyzed, for Ni(II) binding, the 30-amino acid C-terminal fragment of the protein, 
by a combined pH-metric and spectroscopic study. The fragment showed to bind one, two and 
three metal ions depending on the metal to ligand molar ratio. 
      The present work supports the existence of an interesting binding site for Ni(II) at the C-
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